reports
Kforce Inc. Announces Transfer of Listing of Common Stock to the New Y...
Kforce Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange TAMPA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- Kforce Inc. (Nasdaq: KFRC) (“Kforce”), a solutions firm that specializes in technology and professional staffing services, announced today that it will transfer the listing and trading of its common stock to the New York Stock Exchange (“NYSE”) from the Nasdaq Stock Market LLC (“Nasdaq”). Kforce’s common stock is expected to begin trading on the NYSE on May 20, 2024, and will continue to be traded under its current ticker symbol “KFRC.” Kforce’s common st...
- ABGSC Metals & Mining Research
- Adrian Gilani
- Olof Cederholm
Star Shine Holdings Group Ltd: 1 director
A director at Star Shine Holdings Group Ltd sold 60,000,000 shares at 1.200HKD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
B.F. Holding S.p.A: 1 director
A director at B.F. Holding S.p.A bought 6,500 shares at 3.674EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Banco Santander SA: 1 director
A director at Banco Santander SA bought 345,248 shares at 4.570EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders MALVERN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced that Maria Maccecchini, Founder, President, and CEO of Annovis, issued a letter to stockholders providing a review of Phase II/III data from its Alzheimer’s study and sharing next steps. Dear Friends, The last few days have been very difficult. I received a lot of emails and phone calls that often expressed ange...
Spectral Medical Provides April Tigris Trial Update
Spectral Medical Provides April Tigris Trial Update • 105 patients enrolled • April represents a record breaking month for patient enrollment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. Enrollment: Robust enro...
Plus Therapeutics Announces Private Placement Financing of up to $18 M...
Plus Therapeutics Announces Private Placement Financing of up to $18 Million $6.5 million in upfront gross proceeds with the potential to receive up to an additional $11.5 million in potential warrant exercise proceeds for an aggregate of up to approximately $18 million in total gross proceeds AUSTIN, Texas, May 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that it has entered into a securities purchase ag...
Tyson Foods Reports Second Quarter 2024 Results
Tyson Foods Reports Second Quarter 2024 Results Year-Over-Year Growth in Operating Income Highlights Progress on Strategic Initiatives SPRINGDALE, Ark., May 06, 2024 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp and State Fair, reported the following results: (in millions, except per share data)Second Quarter Six Months Ended 2024 2023 2024 2023Sales$ 13,072 ...
Distribution Solutions Group to Participate in Two Conferences: Barrin...
FORT WORTH, Texas--(BUSINESS WIRE)-- Distribution Solutions Group, Inc. (NASDAQ: DSGR) (“DSG” or the “Company"), a premier, multi-platform specialty distribution company today announced that management is participating in the following conferences, which include one-on-one meetings: 18th Annual Barrington Research Virtual Spring Investment Conference on Thursday, May 16, 2024 KeyBanc Capital Markets Industrials & Basic Materials Conference in Boston on Thursday, May 30, 2024 Presentations will be webcast and can be accessed through the investor relations section of the company’s websi...
Dime Announces Expansion in Williamsburg With Deposit-Focused Group
Dime Announces Expansion in Williamsburg With Deposit-Focused Group Dime continues to execute on growth plan HAUPPAUGE, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that it has hired a deposit-focused Group that will cover the Williamsburg market. The Group will be led by John McDonough and Emanuel “Manny” Diconimakis. The Group was previously employed with the former Signature Bank and its successor, Flagstar Bank. Stuart H. Lubow, President and Chief E...
ADC Therapeutics Announces $105 Million Underwritten Offering of Commo...
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants LAUSANNE, Switzerland, May 06, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it has agreed to sell, by way of an underwritten offering, 13,411,912 of its common shares at a price of $4.900 per share and, to certain investors who so choose in lieu of common shares, pre-funded warrants to purchase 8,163,265 common shares at a price of $4.812 per pre-funded warrant (being the offering price per common share in the offering minus the exercise price). The gro...
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financ...
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024 CINCINNATI, May 06, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, May 16, 2024, at 10:00 a.m. (ET). The call-in num...
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it will participate at two investor conferences in May: Citizens JMP Life Sciences Conference Fireside Chat Date:...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
Verkkokauppa.com Oyj: 1 director
A director at Verkkokauppa.com Oyj sold 280,000 shares at 2.200EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Allot Announces the Appointment of Eyal Harari as Chief Executive Offi...
Allot Announces the Appointment of Eyal Harari as Chief Executive Officer Hod Hasharon, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appointment of Eyal Harari as its Chief Executive Officer effective May 6, 2024. He will be replacing Mr. Erez Antebi. At the request of the company's Board of Directors, Mr. Antebi has agreed to assist Mr. Harari during a transition period and thereafter, to continue to provide co...
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced that Jay Skyler, MD, MACP, FRCP has been appointed to the company’s Board of Directors. “Dr. Skyler’s appointment to our Board of Directors is a major milestone for SAB,” said Samuel J. Reich, SAB’s chairman...
Flow Capital Announces Repayment of USD 4.5 Million Investment
Flow Capital Announces Repayment of USD 4.5 Million Investment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV: FW) ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on providing flexible growth financing solutions to small and mid-cap high-growth companies across multiple sectors. With the help of our capital, companies are better able to execute their growth plans, scale their operations more aggres...
N2OFF: Save Foods to Target California’s Hemp Market
N2OFF: Save Foods to Target California’s Hemp Market More than half of US hemp flower grown in California recently received Pre-Harvest Regulatory Approval in California allowing Save Foods to treat hemp Neve Yarak, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- \ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. (“Save Foods”) is set to target the hemp flower market in California. The Company recently announced that the California Depar...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.